• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

(-)-雪松宁负载的聚(D,L-丙交酯-共-乙交酯)微球用于恰加斯病。

(-)-Hinokinin-loaded poly(D,-lactide-co-glycolide) microparticles for Chagas disease.

机构信息

Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, Avenida do Café s/n, 14040-903 Ribeirão Preto, SP, Brazil.

出版信息

Parasitol Res. 2010 Feb;106(3):703-8. doi: 10.1007/s00436-010-1725-1. Epub 2010 Jan 28.

DOI:10.1007/s00436-010-1725-1
PMID:20107838
Abstract

The (-)-hinokinin display high activity against Trypanosoma cruzi in vitro and in vivo. (-)-Hinokinin-loaded poly(D,L-lactide-co-glycolide) microparticles were prepared and characterized in order to protect (-)-hinokinin of biological interactions and promote its sustained release for treatment of Chagas disease. The microparticles contain (-)-hinokinin were prepared by the classical method of the emulsion/solvent evaporation. The scanning electron microscopy, light-scattering analyzer were used to study the morphology and particle size, respectively. The encapsulation efficiency was determined, drug release studies were kinetically evaluated, and the trypanocidal effect was evaluated in vivo. (-)-Hinokinin-loaded microparticles obtained showed a mean diameter of 0.862 microm with smooth surface and spherical shape. The encapsulation efficiency was 72.46 +/- 2.92% and developed system maintained drug release with Higuchi kinetics. The preparation method showed to be suitable, since the morphological characteristics, encapsulation efficiency, and in vitro release profile were satisfactory. In vivo assays showed significant reduction of mice parasitaemia after administration of (-)-hinokinin-loaded microparticles. Thus, the developed microparticles seem to be a promising system for sustained release of (-)-hinokinin for treatment of Chagas disease.

摘要

(-)-扁柏酚显示出对体外和体内 Trypanosoma cruzi 的高活性。为了保护 (-)-扁柏酚免受生物相互作用的影响并促进其持续释放以治疗恰加斯病,制备并表征了负载 (-)-扁柏酚的聚(D,L-丙交酯-共-乙交酯)微球。通过乳液/溶剂蒸发的经典方法制备负载 (-)-扁柏酚的微球。使用扫描电子显微镜和光散射分析仪分别研究形态和粒径。测定包封效率,进行动力学评估药物释放研究,并进行体内抗锥虫作用评价。获得的负载 (-)-扁柏酚的微球平均直径为 0.862 微米,表面光滑,呈球形。包封效率为 72.46 +/- 2.92%,开发的系统以 Higuchi 动力学维持药物释放。该制备方法是合适的,因为形态特征、包封效率和体外释放曲线令人满意。体内试验表明,给予负载 (-)-扁柏酚的微球后,小鼠寄生虫血症显著减少。因此,开发的微球似乎是一种有前途的持续释放 (-)-扁柏酚治疗恰加斯病的系统。

相似文献

1
(-)-Hinokinin-loaded poly(D,-lactide-co-glycolide) microparticles for Chagas disease.(-)-雪松宁负载的聚(D,L-丙交酯-共-乙交酯)微球用于恰加斯病。
Parasitol Res. 2010 Feb;106(3):703-8. doi: 10.1007/s00436-010-1725-1. Epub 2010 Jan 28.
2
Evaluation of the in vivo therapeutic properties of (-)-cubebin and (-)-hinokinin against Trypanosoma cruzi.评价 (-)-古巴醇和 (-)-扁柏素对克氏锥虫的体内治疗特性。
Exp Parasitol. 2013 Apr;133(4):442-6. doi: 10.1016/j.exppara.2012.12.005. Epub 2012 Dec 27.
3
In vivo infection by Trypanosoma cruzi: a morphometric study of tissue changes in mice.体内感染克氏锥虫:对小鼠组织变化的形态计量研究。
Parasitol Res. 2013 Jan;112(1):431-6. doi: 10.1007/s00436-012-3048-x. Epub 2012 Jul 27.
4
and cytotoxicity of hinokinin-loaded PLGA microparticle systems against tumoral SiHa cells.并探讨了载 hinokinin 的 PLGA 微球系统对肿瘤 SiHa 细胞的细胞毒性。
Nat Prod Res. 2022 Sep;36(18):4696-4703. doi: 10.1080/14786419.2021.2000409. Epub 2021 Nov 5.
5
Reduction of parasitism tissue by treatment of mice chronically infected with Trypanosoma cruzi with lignano lactones.用木脂素内酯治疗慢性感染克氏锥虫的小鼠,减少寄生虫组织。
Parasitol Res. 2010 Aug;107(3):525-30. doi: 10.1007/s00436-010-1885-z. Epub 2010 May 4.
6
Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.聚(D,L-丙交酯-乙交酯)纳米和微粒的聚合物降解及模型蛋白的体外释放
J Control Release. 2003 Sep 19;92(1-2):173-87. doi: 10.1016/s0168-3659(03)00328-6.
7
Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.制剂参数对利培酮聚(D,L-丙交酯-乙交酯)微球包封率和释放行为的影响
Chem Pharm Bull (Tokyo). 2009 Nov;57(11):1251-6. doi: 10.1248/cpb.57.1251.
8
Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.(-)-荜澄茄素衍生物对克氏锥虫游离无鞭毛体形式的杀锥虫活性。
Bioorg Med Chem Lett. 2005 Jan 17;15(2):303-7. doi: 10.1016/j.bmcl.2004.10.079.
9
Poly(lactide-co-glycolide) microparticles as systems for controlled release of proteins -- preparation and characterization.聚(丙交酯-乙交酯)微粒作为蛋白质控释系统——制备与表征
Acta Pharm. 2004 Sep;54(3):215-29.
10
NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.聚(D,L-丙交酯-共-乙交酯)微球释放神经生长因子。某些制剂参数对包封的神经生长因子稳定性的影响。
J Control Release. 1998 Dec 4;56(1-3):175-87. doi: 10.1016/s0168-3659(98)00086-8.

引用本文的文献

1
Treatment options applied to the preclinical studies using animal models for Chagas Disease: a systematic review and meta-analysis.应用于恰加斯病动物模型临床前研究的治疗选择:系统评价与荟萃分析
F1000Res. 2025 May 16;13:885. doi: 10.12688/f1000research.150723.1. eCollection 2024.
2
From Benznidazole to New Drugs: Nanotechnology Contribution in Chagas Disease.从苯唑达唑到新药:纳米技术在恰加斯病中的贡献。
Int J Mol Sci. 2023 Sep 7;24(18):13778. doi: 10.3390/ijms241813778.
3
In vitro interaction of polyethylene glycol-block-poly(D,L-lactide) nanocapsule devices with host cardiomyoblasts and Trypanosoma cruzi-infective forms.

本文引用的文献

1
Preparation and characterization of chitosan-treated alginate microparticles incorporating all-trans retinoic acid.制备并表征了载全反式维甲酸壳聚糖处理的海藻酸微球。
J Microencapsul. 2009 May;26(3):243-50. doi: 10.1080/02652040802305105.
2
Analysis of initial burst in PLGA microparticles.聚乳酸-羟基乙酸共聚物微球初始突释分析
Expert Opin Drug Deliv. 2008 Jun;5(6):615-28. doi: 10.1517/17425247.5.6.615.
3
In vitro and in vivo activity of lignan lactones derivatives against Trypanosoma cruzi.木脂素内酯衍生物对克氏锥虫的体外和体内活性
聚乙二醇-聚(D,L-乳酸)纳米胶囊与宿主心肌细胞和感染性形式的克氏锥虫的体外相互作用。
Parasitol Res. 2022 Oct;121(10):2861-2874. doi: 10.1007/s00436-022-07618-0. Epub 2022 Aug 16.
4
Review on Experimental Treatment Strategies Against .关于针对……的实验性治疗策略的综述
J Exp Pharmacol. 2021 Mar 31;13:409-432. doi: 10.2147/JEP.S267378. eCollection 2021.
5
An Ethnopharmacological, Phytochemical and Pharmacological Review on Lignans from Mexican spp.《关于墨西哥 spp. 木脂素的民族药理学、植物化学和药理学研究综述》
Molecules. 2018 Aug 8;23(8):1976. doi: 10.3390/molecules23081976.
6
Medicinal Attributes of Lignans Extracted from : Current Developments.从[来源处]提取的木脂素的药用特性:当前进展
ChemistryOpen. 2018 Feb 2;7(2):180-191. doi: 10.1002/open.201700182. eCollection 2018 Feb.
7
In vitro schistosomicidal activity of the lignan (-)-6,6'-dinitrohinokinin (DNHK) loaded into poly(lactic-co-glycolic acid) nanoparticles against Schistosoma mansoni.载有(-)-6,6'-二硝基厚朴酚(DNHK)的聚乳酸-共-羟基乙酸纳米粒对曼氏血吸虫的体外杀血吸虫活性。
Pharm Biol. 2017 Dec;55(1):2270-2276. doi: 10.1080/13880209.2017.1405996.
8
Hinokinin, an emerging bioactive lignan.扁柏脂素,一种新兴的生物活性木脂素。
Molecules. 2014 Sep 17;19(9):14862-78. doi: 10.3390/molecules190914862.
9
Preparation, characterization, and insecticidal activity evaluation of three different formulations of Beauveria bassiana against Musca domestica.球孢白僵菌三种不同剂型的制备、特性描述及对家蝇的杀虫活性评价。
Parasitol Res. 2013 Oct;112(10):3485-95. doi: 10.1007/s00436-013-3529-6. Epub 2013 Jul 17.
10
Mutagenicity and antimutagenicity of (-)-hinokinin a trypanosomicidal compound measured by Salmonella microsome and comet assays.(-)-扁柏宁作为一种杀变形虫化合物的致突变性和抗突变性,通过沙门氏菌微粒体和彗星试验进行测量。
BMC Complement Altern Med. 2012 Oct 31;12:203. doi: 10.1186/1472-6882-12-203.
Parasitol Res. 2007 Mar;100(4):791-5. doi: 10.1007/s00436-006-0327-4. Epub 2006 Oct 12.
4
Detailed 1H and 13C NMR structural assignment of three biologically active lignan lactones.三种生物活性木脂素内酯的详细氢核磁共振(1H NMR)和碳核磁共振(13C NMR)结构归属
Spectrochim Acta A Mol Biomol Spectrosc. 2006 Jan;63(1):234-9. doi: 10.1016/j.saa.2005.04.047.
5
Nanoscale polymer carriers to deliver chemotherapeutic agents to tumours.用于将化疗药物递送至肿瘤的纳米级聚合物载体。
Expert Opin Biol Ther. 2005 Dec;5(12):1557-69. doi: 10.1517/14712598.5.12.1557.
6
Anti-HIV activity of dibenzylbutyrolactone-type lignans from Phenax species endemic in Costa Rica.来自哥斯达黎加特有的菲纳克斯属植物中二苄基丁内酯型木脂素的抗艾滋病毒活性。
J Pharm Pharmacol. 2005 Sep;57(9):1109-15. doi: 10.1211/jpp.57.9.0006.
7
The chemotherapy of chagas' disease: an overview.恰加斯病的化疗:概述
Mini Rev Med Chem. 2005 May;5(5):499-519. doi: 10.2174/1389557053765565.
8
Synthesis and biological activity evaluation of lignan lactones derived from (-)-cubebin.源自(-)-荜澄茄素的木脂内酯的合成及生物活性评价
Bioorg Med Chem Lett. 2005 Feb 15;15(4):1033-7. doi: 10.1016/j.bmcl.2004.12.035.
9
Trypanocidal activity of (-)-cubebin derivatives against free amastigote forms of Trypanosoma cruzi.(-)-荜澄茄素衍生物对克氏锥虫游离无鞭毛体形式的杀锥虫活性。
Bioorg Med Chem Lett. 2005 Jan 17;15(2):303-7. doi: 10.1016/j.bmcl.2004.10.079.
10
Analgesic and anti-inflammatory activities evaluation of (-)-O-acetyl, (-)-O-methyl, (-)-O-dimethylethylamine cubebin and their preparation from (-)-cubebin.(-)-O-乙酰基、(-)-O-甲基、(-)-O-二甲基乙胺荜澄茄素及其从(-)-荜澄茄素制备物的镇痛和抗炎活性评价
Farmaco. 2004 Jan;59(1):55-61. doi: 10.1016/j.farmac.2003.07.012.